VYNE

VYNE TherapeuticsF

Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences

At close

2026-07-22

View Chart

RSI (14)

82.1

Overbought

MACD Hist

0.02

Bullish

ATR (14)

0.05

Normal

Vol Z (20)

-0.17

Normal

RET 20D

+38.0%

Positive

Dist 52W High

-38.5%

Below High

Technical chart

1 Year

Candles, moving averages, and volume using the current RankAlpha theme.

As of 2026-07-22

Price

SMA 20

SMA 50

SMA 200

Trend readout

Technical readout

Trend

Uptrend (SMA20 > SMA50 > SMA200)

Momentum

Positive momentum · 20D +38.0% · 60D +40.6%

RSI / MACD

RSI 82.1 (Overbought) · MACD hist +0.02

Volatility

Volatility normal (Z -0.17)

SMA20

0.71

SMA50

0.68

SMA200

0.56

EMA12

0.77

EMA26

0.72

BB Upper

0.86

BB Mid

0.71

BB Lower

0.55

RET 5D

+17.0%

RET 20D

+38.0%

RET 60D

+40.6%

RET 120D

+58.4%

As of 2026-07-22 • Updated nightlySource: Internal modelMethodology